drugset / Trial / NCT06170918

Dose of Remimazolam in Children for Intubation

NCT06170918

Unknown 40 enrolled Zhihong LU
NaSequentialOpen-labelTreatment

Summary

Remimazolam has demonstrated the potential as a valuable medication for procedural sedation and general anesthesia. However, half effective dose of remimazolam required to prevent cardiovascular response to tracheal intubation when combined with fentanyl in pediatric patients is still unknown.

Timeline

Start
2023-12-20
Primary completion
2024-05-31
Completion
2024-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Remimazolam Small molecule 0.4 mg/kg Intravenous

Indications

No indication recorded.